A short, evidence-grounded conversation about SIRT1 and its place in longevity science.
Speaker 1
...and this is where the NAD⁺ / Sirtuin Axis comes in. SIRT1, specifically, is an NAD⁺-dependent longevity deacetylase. Think of it like a tiny worker in your cells that needs fuel to do its job.
Speaker 2
Right, and that fuel is NAD⁺. So without enough NAD⁺, this crucial longevity enzyme, SIRT1, can’t function optimally. It's a fundamental connection.
Speaker 1
Exactly. Now, one way researchers have tried to activate SIRT1 is through compounds like resveratrol. It's a classic example, partly mimicking the effects of caloric restriction.
Speaker 2
And then we have pterostilbene, which is a methylated resveratrol analog. Studies suggest it activates SIRT1 with better bioavailability than resveratrol, meaning more of it might reach its target.
Speaker 1
But what's still genuinely unknown is the precise extent to which these compounds translate to human longevity or disease prevention in real-world settings over a lifetime. We see these promising effects in vitro and in animal models.
Speaker 2
Absolutely. For instance, we know active SIRT1 promotes autophagy by deacetylating key autophagy proteins – that's been shown in Molecular Cell in 2008. But whether supplementing with resveratrol or pterostilbene reliably extends human lifespan or healthspan beyond what a healthy diet and lifestyle already provide is still unproven.
Speaker 1
It's a huge open question. We understand the molecular mechanisms, but the long-term human impact, especially regarding dose, duration, and individual variability, is where the big unknowns still lie.
Educational research discussion only — not medical advice. Statements have not been
evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease.
Talk to a qualified clinician before changing any treatment.